Hong Kong stock stays firm | Peg Bio Medicine-B (02565.HK) up over 5% PB-119 listing application approved Company accelerates global commercialization strategy

Wisdom Financial APP learned that BeiGene Biomedical - B (02565.HK) rose more than 5%, as of the time of publication, up 5.11% to HK$63.8, with a turnover of HK$29.2559 million.